SCHEMBL19768248

SCHEMBL19768248

c1cc(-c2ccc3ccc4ccccc4c3n2)cc(-c2ccc3ccc4ccc(-c5ccc6ccccc6c5)nc4c3n2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ AR P10275 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ GFER P55789 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ CYP1A1 P04798 1/20 0.45
▸ CYP1B1 Q16678 1/20 0.45
▸ CYP1A2 P05177 5/20 0.44
▸ CYP11B1 P15538 2/20 0.44
▸ CYP11B2 P19099 2/20 0.44
▸ CYP17A1 P05093 1/20 0.44
▸ CYP19A1 P11511 1/20 0.44
▸ PIM1 P11309 1/20 0.43
▸ MAOA P21397 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19768467 0.98 CYP11B1 (0.46) SMN1; SMN2ALDH1A1NPC1RAB9AAR
SCHEMBL20208243 0.92 PARP1 (0.46) ALDH1A1NPC1RAB9AARMAPT
SCHEMBL10032275 0.92 CYP1A1 (0.51) SMN1; SMN2ALDH1A1NPC1RAB9AAR
SCHEMBL10032531 0.90 CYP11B1 (0.47) SMN1; SMN2ALDH1A1NPC1RAB9AAR
SCHEMBL10032315 0.90 CYP11B1 (0.53) SMN1; SMN2ALDH1A1NPC1RAB9AAR
SCHEMBL19768249 0.89 PARP1 (0.40) SMN1; SMN2ALDH1A1NPC1RAB9AAR
SCHEMBL24475262 0.88 CYP1A1 (0.57) SMN1; SMN2ALDH1A1NPC1RAB9AAR
SCHEMBL12577829 0.87 CYP17A1 (0.40) SMN1; SMN2ALDH1A1NPC1RAB9AAR
SCHEMBL21103767 0.87 CYP1A1 (0.56) SMN1; SMN2ALDH1A1NPC1RAB9AAR
SCHEMBL19768155 0.87 CYP1A2 (0.47) SMN1; SMN2ALDH1A1NPC1RAB9AAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 — — US disclosed
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT SUN2, PAH, FARS2 SMN1; SMN2 4613/4885ALDH1A1 1297/4885NPC1 4176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback